Vaccine Coverage and Primary Sjögren'Syndrome

NCT04224454 | Completed

• 1 other identifier: RECHMPL19_0612
• Study Type: observational
• Target: 111
• Locations: 1 country
• Sites: 1

Brief Summary

Evaluation of vaccination coverage for influenza, pneumococcus and DTP in patients with pSS and investigated the reasons for non-vaccination.

Conditions

Primary Sjögren Syndrome

Keywords

Vaccine; Coverage; Sjögren's syndrome

Outcome Measures

Primary Outcomes (3)

• Rate of patients with Sjögren's syndrome vaccinated against influenzae virus

  Rate of patients with Sjögren's syndrome vaccinated against influenzae virus: number of patients vaccinated against influenzae virus within 1 year divided to the number of patients not vaccinated against influenzae virus within 1 year

  1 year

• Rate of patients with Sjögren's syndrome vaccinated against streptococcus pneumoniae

  Rate of patients with Sjögren's syndrome vaccinated against streptococcus pneumoniae: number of patients vaccinated against streptococcus pneumoniae within 5 years divided to the number of patients not vaccinated against streptococcus pneumoniae within 5 years

  5 years

• Rate of patients with Sjögren's syndrome vaccinated against DTP

  Rate of patients with Sjögren's syndrome vaccinated against DTP : number of patients vaccinated for DTP within 10 years divided to the number of patients not vaccinated for DTP within 10 years

  10 years

Secondary Outcomes (1)

• Evaluate the reasons for non-vaccination

  1 day

Study Arms (1)

Primary Sjögren's syndrome

111 consecutive patients with primary Sjögren's syndrome (European-American 2002 criteria)

Other: Questionnaire

Interventions

Questionnaire OTHER

Questionnaire was adapted from questionnaires used by the French national agency "Institut de Veille Sanitaire" to study vaccination coverage and were completed with the assistance of one fellow to limit missing data.

Primary Sjögren's syndrome

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Consecutive patients with primary Sjögren'syndrome

You may qualify if:

• \- patients with pSS according to European-American Diagnostic Criteria

You may not qualify if:

• \- Refusal to participate

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

Related Publications (1)

• Gluthmann J FL, Bonmarin I, Levy-Bruhl D. Enquête nationale de couverture vaccinale, France, janvier 2011. http://www.invs.sante.fr. . 2001.

  BACKGROUND

MeSH Terms

Conditions

Sjogren's Syndrome

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Arthritis, Rheumatoid; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Xerostomia; Salivary Gland Diseases; Mouth Diseases; Stomatognathic Diseases; Dry Eye Syndromes; Lacrimal Apparatus Diseases; Eye Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Jacques MOREL, Professor

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 2, 2020
• First Posted: January 13, 2020
• Study Start: January 1, 2016
• Primary Completion: November 1, 2017
• Study Completion: November 30, 2017
• Last Updated: January 13, 2020

Record last verified: 2020-01

Locations

FR (1)